Rangeley Capital »

Replimune Group shares owned by Rangeley Capital

Quarter-by-quarter ownership of Replimune Group (REPL) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $44k 10k 4.19

More positions owned by Rangeley Capital

Delek Us Holdings (DK)
Calumet (CLMT)
Arvinas Ord (ARVN)
Prothena Corp SHS (PRTA)
Wideopenwest (WOW)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Yext (YEXT)
Keros Therapeutics (KROS)
Arbutus Biopharma (ABUS)
Seaport Entmt Group Common Stock (SEG)
Berto Acquisition Corp Ord Shs (TACO)
Charter Communications Inc N Cl A (CHTR)
Full House Resorts (FLL)
Surgery Partners (SGRY)
Core Scientific *w Exp 01/23/202 (CORZW)

View all positions for Rangeley Capital

Top funds holding Replimune Group

Baker Bros. Advisors
Rtw Investments
BlackRock
Fcpm Iii Services B.v.
Point72 Asset Management
Ally Bridge Group
Susquehanna International
Vanguard Group
Tang Capital Management
State Street Corporation
Braidwell
Balyasny Asset Management
Readystate Asset Management
Millennium Management
Geode Capital Management

View all funds holding Replimune Group